RU2018144784A3 - - Google Patents

Download PDF

Info

Publication number
RU2018144784A3
RU2018144784A3 RU2018144784A RU2018144784A RU2018144784A3 RU 2018144784 A3 RU2018144784 A3 RU 2018144784A3 RU 2018144784 A RU2018144784 A RU 2018144784A RU 2018144784 A RU2018144784 A RU 2018144784A RU 2018144784 A3 RU2018144784 A3 RU 2018144784A3
Authority
RU
Russia
Application number
RU2018144784A
Other languages
Russian (ru)
Other versions
RU2018144784A (ru
RU2751504C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018144784A publication Critical patent/RU2018144784A/ru
Publication of RU2018144784A3 publication Critical patent/RU2018144784A3/ru
Application granted granted Critical
Publication of RU2751504C2 publication Critical patent/RU2751504C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2018144784A 2016-05-19 2017-05-18 Применение карбамата для предупреждения или лечения невралгии тройничного нерва RU2751504C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0061386 2016-05-19
KR20160061386 2016-05-19
PCT/KR2017/005172 WO2017200317A1 (ko) 2016-05-19 2017-05-18 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (3)

Publication Number Publication Date
RU2018144784A RU2018144784A (ru) 2020-06-19
RU2018144784A3 true RU2018144784A3 (enExample) 2020-08-11
RU2751504C2 RU2751504C2 (ru) 2021-07-14

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018144784A RU2751504C2 (ru) 2016-05-19 2017-05-18 Применение карбамата для предупреждения или лечения невралгии тройничного нерва

Country Status (14)

Country Link
US (2) US11207295B2 (enExample)
EP (1) EP3459542B1 (enExample)
JP (1) JP6960415B2 (enExample)
KR (1) KR102421013B1 (enExample)
CN (1) CN109310669B (enExample)
AU (1) AU2017267160B2 (enExample)
CA (1) CA3024284C (enExample)
DK (1) DK3459542T3 (enExample)
ES (1) ES2887338T3 (enExample)
MX (1) MX389613B (enExample)
PL (1) PL3459542T3 (enExample)
PT (1) PT3459542T (enExample)
RU (1) RU2751504C2 (enExample)
WO (1) WO2017200317A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3035674T3 (en) 2016-12-14 2025-09-08 Sk Biopharmaceuticals Co Ltd Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
IL281559B2 (en) * 2018-09-21 2025-06-01 Sk Biopharmaceuticals Co Ltd (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder
KR20210062029A (ko) 2018-10-19 2021-05-28 에스케이바이오팜 주식회사 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) * 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
EP0959882A4 (en) * 1996-12-31 2001-12-05 N-BONDED UREAUTIES AND CARBAMATES OF HETEROCYCLIC THIOESTERS
MXPA03007721A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuesto de carbamato para su uso en el tratamiento del dolor.
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) * 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
AU2009348523B2 (en) * 2009-06-22 2015-02-26 Sk Biopharmaceuticals Co., Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
KR20140009244A (ko) * 2010-11-11 2014-01-22 애크런 몰레큘스 게엠베하 통증 치료용 화합물 및 방법
SI3054950T1 (sl) * 2014-05-09 2017-12-29 Tecnimede-Sociedade Tecnico-Medicinal, S.A. (r)-pirindol in njegove farmacevtsko sprejemljive soli za uporabo v medicini

Also Published As

Publication number Publication date
BR112018073556A2 (pt) 2019-03-19
MX2018014081A (es) 2019-09-02
AU2017267160A1 (en) 2018-12-13
CN109310669A (zh) 2019-02-05
EP3459542A4 (en) 2020-01-08
US12611395B2 (en) 2026-04-28
KR20170131241A (ko) 2017-11-29
CN109310669B (zh) 2022-02-22
ES2887338T3 (es) 2021-12-22
RU2018144784A (ru) 2020-06-19
CA3024284A1 (en) 2017-11-23
EP3459542B1 (en) 2021-06-30
US20190175555A1 (en) 2019-06-13
JP2019516722A (ja) 2019-06-20
US11207295B2 (en) 2021-12-28
KR102421013B1 (ko) 2022-07-14
US20220087976A1 (en) 2022-03-24
DK3459542T3 (da) 2021-09-13
EP3459542A1 (en) 2019-03-27
PL3459542T3 (pl) 2021-12-27
MX389613B (es) 2025-03-20
CA3024284C (en) 2024-01-23
RU2751504C2 (ru) 2021-07-14
AU2017267160B2 (en) 2022-11-10
PT3459542T (pt) 2021-08-24
WO2017200317A1 (ko) 2017-11-23
JP6960415B2 (ja) 2021-11-05

Similar Documents

Publication Publication Date Title
BR112018068177A2 (enExample)
BR112019002665A2 (enExample)
BR112018004986A2 (enExample)
BR112019001429A2 (enExample)
BR212018070320U2 (enExample)
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019011445B1 (pt) Molécula de ácido nucleico, vetor, construto, célula hospedeira bacteriana e métodos para transformação, seleção, produção e proteção de células e plantas transgênicas tolerantes a herbicida transgênicas
BR112019006736A2 (enExample)
CN303639205S (zh) 纸巾包装盒
CN303640735S (zh) 带图形用户界面的手机
CN303605336S (zh) 计算机软件界面(gpklpk 002)
CN303536045S (zh) 嫁衣(15)
CN303537535S (zh) 车家床(四六分圆拉床半围)
CN303536111S (zh) 眼罩(条纹)
CN303536110S (zh) 眼罩(花纹)
CN303586832S (zh) Led工矿灯(型材3*1模组)
CN303608616S (zh) 鞋(hodo-h1)
CN303551431S (zh) 发动机短箱左曲轴箱盖(1p52qmi-a)
CN303537405S (zh) 凳子(2076)
CN303536593S (zh) 吊伞(新型弯推)
CN303605737S (zh) 加水器(pl-6)